EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.3.1.22 | 17beta[3-(N-4-bromophenyl)tetrahydrooxazin-2-on-6-yl]androst-4-en-3-one | - |
Homo sapiens | |
1.3.1.22 | 17beta[3-(N-4-chlorophenyl)tetrahydrooxazin-2-on-6-yl]androst-4-en-3-one | - |
Homo sapiens | |
1.3.1.22 | 17beta[3-(N-4-ethoxyphenyl)tetrahydrooxazin-2-on-6-yl]androst-4-en-3-one | - |
Homo sapiens | |
1.3.1.22 | 17beta[3-(N-4-ethylphenyl)tetrahydrooxazin-2-on-6-yl]androst-4-en-3-one | - |
Homo sapiens | |
1.3.1.22 | 17beta[3-(N-4-methoxyphenyl)tetrahydrooxazin-2-on-6-yl]androst-4-en-3-one | - |
Homo sapiens | |
1.3.1.22 | 17beta[3-(N-4-phenyl)tetrahydrooxazin-2-on-6-yl]androst-4-en-3-one | - |
Homo sapiens | |
1.3.1.22 | 17beta[3-(N-4-tolyl)tetrahydrooxazin-2-on-6-yl]androst-4-en-3-one | slight inhibition | Homo sapiens | |
1.3.1.22 | finasteride | i.e. 17beta-(N-tert-butylcarbamoyl)-4-aza-5alpha-androst-1-en-3-one | Homo sapiens | |
1.3.1.22 | additional information | synthesis of diverse steroidal tetrahydrooxazin-2-ones as potential inhibitors of the enzyme, IC50 of inhibitory compounds, overview | Homo sapiens | |
1.3.99.5 | (17beta)-17-(2-oxo-3-phenyl-1,3-oxazinan-6-yl)androst-4-en-3-one | - |
Homo sapiens | |
1.3.99.5 | (17beta)-17-[3-(4-bromophenyl)-2-oxo-1,3-oxazinan-6-yl]androst-4-en-3-one | - |
Homo sapiens | |
1.3.99.5 | (17beta)-17-[3-(4-chlorophenyl)-2-oxo-1,3-oxazinan-6-yl]androst-4-en-3-one | - |
Homo sapiens | |
1.3.99.5 | (17beta)-17-[3-(4-ethoxyphenyl)-2-oxo-1,3-oxazinan-6-yl]androst-4-en-3-one | - |
Homo sapiens | |
1.3.99.5 | (17beta)-17-[3-(4-ethylphenyl)-2-oxo-1,3-oxazinan-6-yl]androst-4-en-3-one | - |
Homo sapiens | |
1.3.99.5 | (17beta)-17-[3-(4-methoxyphenyl)-2-oxo-1,3-oxazinan-6-yl]androst-4-en-3-one | - |
Homo sapiens | |
1.3.99.5 | finasteride | - |
Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.3.1.22 | Homo sapiens | - |
- |
- |
1.3.99.5 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.3.1.22 | prostate | - |
Homo sapiens | - |
1.3.99.5 | prostate gland | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.3.1.22 | testosterone + NADPH + H+ | - |
Homo sapiens | 5alpha-dihydrotestosterone + NADP+ | - |
? | |
1.3.99.5 | testosterone + NADPH + H+ | - |
Homo sapiens | dihydrotestosterone + NADP+ | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.3.99.5 | 5alpha-reductase | - |
Homo sapiens |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
1.3.1.22 | 37 | - |
assay at | Homo sapiens |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.3.1.22 | NADPH | - |
Homo sapiens |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
1.3.99.5 | 0.000055 | - |
37°C | Homo sapiens | finasteride | |
1.3.99.5 | 0.000245 | - |
37°C | Homo sapiens | (17beta)-17-[3-(4-ethoxyphenyl)-2-oxo-1,3-oxazinan-6-yl]androst-4-en-3-one | |
1.3.99.5 | 0.00026 | - |
37°C | Homo sapiens | (17beta)-17-[3-(4-ethylphenyl)-2-oxo-1,3-oxazinan-6-yl]androst-4-en-3-one | |
1.3.99.5 | 0.00027 | - |
37°C | Homo sapiens | (17beta)-17-(2-oxo-3-phenyl-1,3-oxazinan-6-yl)androst-4-en-3-one | |
1.3.99.5 | 0.00042 | - |
37°C | Homo sapiens | (17beta)-17-[3-(4-chlorophenyl)-2-oxo-1,3-oxazinan-6-yl]androst-4-en-3-one | |
1.3.99.5 | 0.0005 | - |
37°C | Homo sapiens | (17beta)-17-[3-(4-bromophenyl)-2-oxo-1,3-oxazinan-6-yl]androst-4-en-3-one | |
1.3.99.5 | 0.0006 | - |
37°C | Homo sapiens | (17beta)-17-[3-(4-methoxyphenyl)-2-oxo-1,3-oxazinan-6-yl]androst-4-en-3-one |